These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 195207

  • 21. Implications of the introduction of the new killed poliomyelitis vaccine into the expanded programme of immunization (EPI).
    Martin JF.
    Trop Geogr Med; 1985 Sep; 37(3):S55-9. PubMed ID: 4084367
    [Abstract] [Full Text] [Related]

  • 22. [Implementing secondary poliomyelitis vaccination].
    Pietsch R, Riegel H.
    Gesundheitswesen; 1992 Dec; 54(12):714-5. PubMed ID: 1366256
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Results of a program successfully combining live and killed polio vaccines.
    Lasch EE, Abed Y, Gerichter CB, Massri ME, Marcus O, Hensher R, Goldblum N.
    Isr J Med Sci; 1983 Nov; 19(11):1021-3. PubMed ID: 6662685
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
    Laassri M, Lottenbach K, Belshe R, Rennels M, Plotkin S, Chumakov K.
    J Infect Dis; 2006 May 15; 193(10):1344-9. PubMed ID: 16619180
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE.
    Dev Biol Stand; 1979 May 15; 43():187-93. PubMed ID: 230109
    [No Abstract] [Full Text] [Related]

  • 29. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M, Hovi L, Siimes MA, Roivainen M, Hovi T.
    Pediatr Infect Dis J; 1987 Dec 15; 6(12):1106-10. PubMed ID: 2829105
    [Abstract] [Full Text] [Related]

  • 30. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
    Gudnadóttir M.
    Dev Biol Stand; 1981 Dec 15; 47():257-9. PubMed ID: 7227654
    [Abstract] [Full Text] [Related]

  • 31. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
    Assaad F.
    Dev Biol Stand; 1981 Dec 15; 47():275-82. PubMed ID: 6262152
    [No Abstract] [Full Text] [Related]

  • 32. Need for polio boosters after age two years.
    Rennels MB.
    Vaccine; 2009 Jan 07; 27(2):179-80. PubMed ID: 19007837
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ.
    Bull World Health Organ; 2004 Jan 07; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [Abstract] [Full Text] [Related]

  • 35. Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.
    Lasch EE, Abed Y, Abdulla K, El Tibbi AG, Marcus O, El Massri M, Handscher R, Gerichter CB, Melnick JL.
    Rev Infect Dis; 1984 Jan 07; 6 Suppl 2():S467-70. PubMed ID: 6740094
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Current poliomyelitis immunization policy in the United States.
    Sutter RW, Onorato IM, Patriarca PA.
    Pediatr Ann; 1990 Dec 07; 19(12):702-6. PubMed ID: 2177873
    [No Abstract] [Full Text] [Related]

  • 39. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan 15; 259(3):345-6. PubMed ID: 3336150
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.